Multiplex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD354; Triggering Receptor Expressed On Monocytes-1

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-93 88
EDTA plasma(n=5) 90-101 97
heparin plasma(n=5) 88-95 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-94% 84-99% 88-95% 95-102%
EDTA plasma(n=5) 94-105% 80-102% 99-105% 79-104%
heparin plasma(n=5) 94-101% 78-89% 96-105% 82-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:TREM1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Pharmacology and Experimental Therapeutics Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages Aspet: 171462
Arthritis Research & Therapy Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine. pubmed:27624724
Chinese medical journal Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8+ T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis PMC5443028
Journal of Maternal-Fetal & Neonatal Medicine Increased TLR4 and TREM-1 expression on monocytes and neutrophils in preterm birth: further evidence of a proinflammatory state Pubmed:29534643
Journal of Maternal-Fetal & Neonatal Medicine A promising novel biomarker for early-onset preeclampsia: soluble trigger receptor expressed on myeloid cells-1 (sTREM-1) Pubmed: 33207989
Ioannis Gkougkourellas, Alexandros Sarantopoulos, Konstantinos Tselios, Athanasios Kalogeridis
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
EPA213Hu61 Eukaryotic Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Positive Control; Immunogen; SDS-PAGE; WB.
APA213Hu61 Active Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Cell culture; Activity Assays.
RPA213Hu01 Recombinant Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA213Hu01 Polyclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) WB; IHC; ICC; IP.
FAA213Hu01 Anti-Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Polyclonal Antibody Flow cytometry.
MAA213Hu22 Monoclonal Antibody to Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) WB; IHC; ICC; IP.
SEA213Hu ELISA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA213Hu CLIA Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) Chemiluminescent immunoassay for Antigen Detection.
LMA213Hu Multiplex Assay Kit for Triggering Receptor Expressed On Myeloid Cells 1 (TREM1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.